Annual Report for FY 2024-25
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indegene Ltd has filed its Annual Report for FY 2024-25 along with the notice for its 27th Annual General Meeting, scheduled for June 26, 2025, at 4:30 p.m. IST via video conferencing. For the year, the company reported revenue of ₹28,393 million (up 9.6% YoY), EBITDA of ₹5,622 million (up 5%), and profit after tax of ₹4,067 million (up 20.8%), with a maiden dividend announced. It launched 'Cortex', a GenAI platform purpose-built for life sciences, and acquired MJL Life Sciences to expand healthcare communications in the UK. The company has 5,000+ employees across 19 global offices, serves 73 active clients including 20 of the world's top biopharma companies, and earned a Silver rating from EcoVadis for sustainability. The report is being sent electronically to shareholders, with web-link letters dispatched to those without registered email IDs.
The filing is a routine regulatory disclosure (annual report submission) rather than a price-moving event, but it highlights strong profit growth (PAT +20.8%) and a maiden dividend, signalling financial maturity. Shareholders now have access to the full-year report and AGM agenda ahead of the June 26 meeting.